Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 646 AL 660

Agents at the Peak of US FDA Approval for the Treatment of Alzheimer's Disease

Alam J, Kalash A, Hassan MI, Rahman SZ.

Neurol Res. 2024 Apr;46(4):318-325. doi: 10.1080/01616412.2024.2302271. Epub 2024 Jan 10.

Multi-Target-Directed Cinnamic Acid Hybrids Targeting Alzheimer's Disease

Drakontaeidi A, Pontiki E.

Int J Mol Sci. 2024 Jan 1;25(1):582. doi: 10.3390/ijms25010582.

Passive immunotherapy for Alzheimer's disease

Guo X, Yan L, Zhang D, Zhao Y.

Ageing Res Rev. 2024 Feb;94:102192. doi: 10.1016/j.arr.2024.102192. Epub 2024 Jan 14.

Antioxidant, anti-inflammatory and epigenetic potential of curcumin in Alzheimer's disease

Abdul-Rahman T, Awuah WA, Mikhailova T, Kalmanovich J, Mehta A, Ng JC, Coghlan MA, Zivcevska M, Tedeschi AJ, de Oliveira EC, Kumar A, Cantu-Herrera E, Lyndin M, Sikora K, Alexiou A, Bilgrami AL, Al-Ghamdi KM, Perveen A, Papadakis M, Ashraf GM.

Biofactors. 2024 Jul-Aug;50(4):693-708. doi: 10.1002/biof.2039. Epub 2024 Jan 16.

Alzheimer's disease, aging, and cannabidiol treatment: a promising path to promote brain health and delay aging

Liu Y.

Mol Biol Rep. 2024 Jan 16;51(1):121. doi: 10.1007/s11033-023-09162-1.

TREM2 in Alzheimer's disease: Structure, function, therapeutic prospects, and activation challenges

Zgorzynska E.

Mol Cell Neurosci. 2024 Mar;128:103917. doi: 10.1016/j.mcn.2024.103917. Epub 2024 Jan 19.

Talking With Patients About the New Anti-amyloid Alzheimer Disease Medications

Sarkisian CA, Romanov A, Mafi JN.

Ann Intern Med. 2024 Feb;177(2):246-248. doi: 10.7326/M23-3377. Epub 2024 Jan 23.

Immunotherapy in Alzheimer's Disease: From the Bench to the Bedside

Diniz BS.

Am J Geriatr Psychiatry. 2024 May;32(5):584-585. doi: 10.1016/j.jagp.2024.01.013. Epub 2024 Jan 14.

Mapping racial and ethnic healthcare disparities for persons living with dementia: A scoping review

Hinton L, Tran D, Peak K, Meyer OL, Quiñones AR.

Alzheimers Dement. 2024 Apr;20(4):3000-3020. doi: 10.1002/alz.13612. Epub 2024 Jan 24.

Current Advances and Future Perspectives on Mesenchymal Stem Cell-Derived Extracellular Vesicles in Alzheimer's Disease

Zhang W, Uyemura R, Zhong K, Guo R, Zhong L.

Aging Dis. 2024 Oct 1;15(5):2015-2027. doi: 10.14336/AD.2023.1206.

Understanding the mechanisms of disease modifying effects of aerobic exercise in people with Alzheimer's disease

Abdullahi A, Wong TW, Ng SS.

Ageing Res Rev. 2024 Feb;94:102202. doi: 10.1016/j.arr.2024.102202. Epub 2024 Jan 23.

Sulfonamide Derivatives: Recent Compounds with Potent Anti-alzheimer's Disease Activity

Egbujor MC.

Cent Nerv Syst Agents Med Chem. 2024;24(1):82-104. doi: 10.2174/0118715249278489231128042135.

Disentangling tau: One protein, many therapeutic approaches

Lane-Donovan C, Boxer AL.

Neurotherapeutics. 2024 Mar;21(2):e00321. doi: 10.1016/j.neurot.2024.e00321. Epub 2024 Jan 25.

Lessons Learned from Approval of Aducanumab for Alzheimer's Disease

Heidebrink JL, Paulson HL.

Annu Rev Med. 2024 Jan 29;75:99-111. doi: 10.1146/annurev-med-051022-043645.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias